ciprofloxacin has been researched along with Bacterial Skin Diseases in 73 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Ciprofloxacin or doxycycline is recommended for antimicrobial prophylaxis and treatment of adults and children with Bacillus anthracis infection associated with the recent bioterrorist attacks in the United States." | 3.71 | Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. ( , 2001) |
"While being treated with corticosteroids and methotrexate for rheumatoid arthritis, a 63-year-old man developed livid nodules on his lower arms, hands and feet, as well as fever, necrotizing skin ulcers and rupture of a finger extensor tendon." | 3.71 | [Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis]. ( Böcher, W; Galle, PR; Märker-Hermann, E, 2002) |
" Drug-related adverse events were reported by 8." | 2.69 | A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. ( Jasovich, A; Neto, W; Nicodemo, AC; Robledo, JA, 1998) |
"Anthrax is still an endemic disease in some countries in the world and has become a re-emerging disease in western countries with recent intentional outbreak." | 2.46 | A review of cutaneous anthrax and its outcome. ( Alp, E; Doganay, M; Metan, G, 2010) |
"Cutaneous diphtheria is a rare infection in the United States." | 2.44 | Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections. ( English, JC; Lee, PL; Lemos, B; O'Brien, SH; Zirwas, MJ, 2007) |
"In a mouse skin wound infection model, F6 was equipotent to the antibiotic fusidic acid in reducing MRSA burden." | 1.48 | N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria. ( Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO, 2018) |
"Anthrax is an endemic disease in developing countries." | 1.43 | Cutaneous anthrax: evaluation of 28 cases in the Eastern Anatolian region of Turkey. ( Akbulut, A; Demir, B; Denk, A; Ozden, M; Tartar, AS, 2016) |
"Cutaneous anthrax is an infection of the skin caused by Bacillus anthracis." | 1.40 | Cutaneous anthrax in a school teacher. ( Alam, MA; Baidya, NR; Kamal, MM; Mostafa, SM; Nandi, AK; Rahman, F; Uddin, MJ, 2014) |
"Anthrax is a rare disease caused by Bacillus anthracis." | 1.39 | Evaluation of cutaneous palpebral anthrax. ( Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R, 2013) |
"Anthrax is occasionally encountered by U." | 1.39 | Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system. ( Krivda, S; Norton, SA; Pace, S; Steigelman, D, 2013) |
"Tularemia is a worldwide zoonosis caused by Francisella tularensis." | 1.38 | Cavitary pneumonia and skin lesions. ( Alvela-Suárez, L; Belhassen-Garcia, M; Carpio-Pérez, A; Fraile-Alonso, Mdel C; Pardo-Lledias, J; Velasco-Tirado, V, 2012) |
"Anthrax was suspected primarily based on cutaneous manifestations of typical non-tender ulcer with black eschar, with or without oedema, and a history of butchering, or dressing/washing of cattle/goat or their meat." | 1.38 | Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital. ( Ahmed, SS; Akhtaruzzaman, SM; Anwar, KS; Khan, MA; Salam, MA; Siddiqui, MA, 2012) |
"If left untreated, cutaneous anthrax may progress in 5 to 20% of cases to septicaemia with potentially lethal central nervous system involvement." | 1.35 | [Cutaneous anthrax: seven cases]. ( Alifadl, A; Azouzi, AI; Bjani, L; Chraibi, H; Gaamouche, K; Haouach, K; Kaidi, A; Khalidi, TE; Mountasser, A, 2009) |
"Incidence of anthrax is diminishing in developed countries; however, it remains a public health problem in developing countries, especially those whose main source of income is farming." | 1.35 | Characteristics of cutaneous anthrax in Turkey. ( Baykam, N; Celikbas, A; Dokuzoguz, B; Eren, S; Ergonul, O; Eroglu, M; Ulu, A, 2009) |
"Although cutaneous anthrax is usually self-limiting, complications may arise in untreated cases." | 1.33 | An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus. ( Ayaslioglu, E; Beygo, B; Erkek, E; Ozluk, U, 2005) |
" This report updates the investigation of these cases and describes adverse events associated with antimicrobial prophylaxis." | 1.31 | Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. ( , 2001) |
" During October 26-November 6, 2001, an epidemiologic evaluation to detect adverse events associated with antimicrobial prophylaxis was conducted among 8,424 postal employees who had been offered antimicrobial prophylaxis for 60 days in New Jersey (NJ), New York City (NYC), and one postal facility in the District of Columbia (DC)." | 1.31 | Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001. ( , 2001) |
"Ciprofloxacin was also tested against Gram-negative isolates." | 1.31 | Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections. ( Bartizal, K; Gesser, RM; Motyl, M; Pelak, BA; Woods, GL, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (19.18) | 18.2507 |
2000's | 36 (49.32) | 29.6817 |
2010's | 22 (30.14) | 24.3611 |
2020's | 1 (1.37) | 2.80 |
Authors | Studies |
---|---|
Amsler, KM | 1 |
Davies, TA | 1 |
Shang, W | 1 |
Jacobs, MR | 1 |
Bush, K | 1 |
Opoku-Temeng, C | 1 |
Naclerio, GA | 1 |
Mohammad, H | 1 |
Dayal, N | 1 |
Abutaleb, NS | 1 |
Seleem, MN | 1 |
Sintim, HO | 1 |
Kibar Ozturk, M | 1 |
Bartolomé-Álvarez, J | 1 |
Solves-Ferriz, V | 1 |
Reisfeld, L | 1 |
Ikuta, CY | 1 |
Ippolito, L | 1 |
Silvatti, B | 1 |
Ferreira Neto, JS | 1 |
Catão-Dias, JL | 1 |
Rosas, FCW | 1 |
Neto, JA | 1 |
da Silva, VMF | 1 |
Tekin, R | 1 |
Ari, S | 1 |
Dal, T | 1 |
Kaya, S | 1 |
Kortak, MZ | 1 |
Dursun, B | 1 |
Dayan, S | 1 |
Brauns, B | 1 |
Schön, MP | 1 |
Mempel, M | 1 |
Pace, S | 1 |
Steigelman, D | 1 |
Norton, SA | 1 |
Krivda, S | 1 |
Turhanoğlu, NM | 1 |
Bayındır Bilman, F | 1 |
Kutlu Yürüker, S | 1 |
Cowart, DW | 1 |
Moradi, BN | 1 |
Arora, NS | 1 |
Chatterjee, K | 1 |
Chaudhuri, A | 1 |
Chatterjee, G | 1 |
Parlak, E | 2 |
Parlak, M | 2 |
Atli, SB | 1 |
Nandi, AK | 1 |
Kamal, MM | 1 |
Alam, MA | 1 |
Rahman, F | 1 |
Uddin, MJ | 1 |
Baidya, NR | 1 |
Mostafa, SM | 1 |
Denk, A | 1 |
Tartar, AS | 1 |
Ozden, M | 1 |
Demir, B | 1 |
Akbulut, A | 1 |
Flinn, A | 1 |
McDermott, M | 1 |
Butler, KM | 1 |
Tan, M | 1 |
Lee, JS | 1 |
Pan, JY | 1 |
Chraibi, H | 1 |
Haouach, K | 1 |
Azouzi, AI | 1 |
Gaamouche, K | 1 |
Kaidi, A | 1 |
Khalidi, TE | 1 |
Alifadl, A | 1 |
Bjani, L | 1 |
Mountasser, A | 1 |
Grocholski, AS | 1 |
Delage, M | 1 |
Samimi, M | 1 |
Maruani, A | 1 |
Difonzo, EM | 1 |
Campanile, GL | 1 |
Vanzi, L | 1 |
Lotti, L | 1 |
Baykam, N | 1 |
Ergonul, O | 1 |
Ulu, A | 1 |
Eren, S | 1 |
Celikbas, A | 1 |
Eroglu, M | 1 |
Dokuzoguz, B | 1 |
Castro-Silva, AN | 1 |
Freire, AO | 1 |
Grinbaum, RS | 1 |
Elmor de Araújo, MR | 1 |
Abensur, H | 1 |
Araújo, MR | 1 |
Romão, JE | 1 |
Sampaio, JL | 1 |
Noronha, IL | 1 |
Doganay, M | 2 |
Metan, G | 2 |
Alp, E | 1 |
Duncan, KO | 1 |
Smith, TL | 1 |
Kay, MK | 1 |
Perti, TR | 1 |
Duchin, JS | 1 |
Belhassen-Garcia, M | 1 |
Velasco-Tirado, V | 1 |
Alvela-Suárez, L | 1 |
Fraile-Alonso, Mdel C | 1 |
Carpio-Pérez, A | 1 |
Pardo-Lledias, J | 1 |
Kayabas, U | 1 |
Karahocagil, MK | 1 |
Ozkurt, Z | 1 |
Bayindir, Y | 1 |
Kalkan, A | 1 |
Akdeniz, H | 1 |
Simpson, AJ | 1 |
Siddiqui, MA | 1 |
Khan, MA | 1 |
Ahmed, SS | 1 |
Anwar, KS | 1 |
Akhtaruzzaman, SM | 1 |
Salam, MA | 1 |
Coutinho, AS | 1 |
de Morais, OO | 1 |
Gomes, CM | 1 |
de Oliveira Carneiro da Motta, J | 1 |
Rao, J | 1 |
Golden, TA | 1 |
Fitzpatrick, RE | 1 |
Marzano, AV | 1 |
Mercogliano, M | 1 |
Borghi, A | 1 |
Facchetti, M | 1 |
Caputo, R | 1 |
Iakovlev, VP | 2 |
Svetukhin, AM | 1 |
Blatun, LA | 1 |
Ukhin, SA | 1 |
Godyn, JJ | 1 |
Reyes, L | 1 |
Siderits, R | 1 |
Hazra, A | 1 |
Fragoulis, KN | 1 |
Klouvas, GD | 1 |
Falagas, ME | 1 |
Erkek, E | 1 |
Ayaslioglu, E | 1 |
Beygo, B | 1 |
Ozluk, U | 1 |
Yetkin, MA | 1 |
Erdinc, FS | 1 |
Bulut, C | 1 |
Tulek, N | 1 |
Qadir, SN | 1 |
Raza, N | 1 |
Rahman, SB | 1 |
Lee, PL | 1 |
Lemos, B | 1 |
O'Brien, SH | 1 |
English, JC | 1 |
Zirwas, MJ | 1 |
Yu, Y | 1 |
Cheng, AS | 1 |
Wang, L | 1 |
Dunne, WM | 1 |
Bayliss, SJ | 1 |
Roé, E | 1 |
Barnadas, MA | 1 |
Bergua, P | 1 |
Sancho, F | 1 |
Matas, L | 1 |
Paredes, R | 1 |
Pujol, J | 1 |
Alomar, A | 1 |
Lorian, V | 1 |
Pavletich, K | 1 |
Zahid, MA | 1 |
Klotz, SA | 1 |
Goldstein, E | 1 |
Bartholomew, W | 1 |
Delaporte, E | 1 |
Savage, C | 1 |
Alfandari, S | 1 |
Piette, F | 1 |
Leclerc, H | 1 |
Bergoend, H | 1 |
Clark, JA | 1 |
Margolis, DM | 1 |
Liu, HH | 1 |
Bolash, NK | 1 |
McAnany, ME | 1 |
Lynch, RA | 1 |
Hachem, R | 1 |
Raad, I | 1 |
Rolston, KV | 1 |
Whimbey, E | 1 |
Katz, R | 1 |
Tarrand, J | 1 |
Libshitz, H | 1 |
Braun, H | 1 |
Autenrieth, IB | 1 |
Schuster, V | 1 |
Ewald, J | 1 |
Harmsen, D | 1 |
Kreth, HW | 1 |
Nicodemo, AC | 1 |
Robledo, JA | 1 |
Jasovich, A | 1 |
Neto, W | 1 |
Niang, M | 1 |
Debat Zoguereh, D | 1 |
Badiaga, S | 1 |
Brouqui, P | 1 |
Krumpe, PE | 1 |
Cohn, S | 1 |
Garreltes, J | 1 |
Ramirez, J | 1 |
Coulter, H | 1 |
Haverstock, D | 1 |
Echols, R | 1 |
Martinez, JG | 1 |
Semret, M | 1 |
Koromihis, G | 1 |
MacLean, JD | 1 |
Libman, M | 1 |
Ward, BJ | 1 |
Ghosh, SK | 1 |
Wolfe, J | 1 |
Turenne, C | 1 |
Alfa, M | 1 |
Harding, G | 1 |
Thibert, L | 1 |
Kabani, A | 1 |
Lemonick, MD | 1 |
SoRelle, R | 1 |
Gallagher, TC | 1 |
Strober, BE | 1 |
Blondeau, JM | 1 |
Tutrone, WD | 1 |
Scheinfeld, NS | 1 |
Weinberg, JM | 1 |
Böcher, W | 1 |
Galle, PR | 1 |
Märker-Hermann, E | 1 |
Celia, F | 1 |
Pelak, BA | 1 |
Bartizal, K | 1 |
Woods, GL | 1 |
Gesser, RM | 1 |
Motyl, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients[NCT00050310] | 200 participants (Anticipated) | Observational | 2002-10-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
8 reviews available for ciprofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
A review of cutaneous anthrax and its outcome.
Topics: Adolescent; Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; D | 2010 |
[Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Ciprofloxacin; Gastro | 2004 |
Cutaneous anthrax: conservative or surgical treatment?
Topics: Anthrax; Anti-Bacterial Agents; Biopsy; Bioterrorism; Ciprofloxacin; Diagnosis, Differential; Doxycy | 2005 |
Cutaneous diphtheroid infection and review of other cutaneous Gram-positive Bacillus infections.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium diphtheriae; | 2007 |
[Use of ciprofloxacin in the treatment and prevention of surgical infections].
Topics: Anti-Infective Agents; Bacterial Infections; Bone Diseases, Infectious; Ciprofloxacin; Humans; Joint | 1999 |
The role of fluoroquinolones in skin and skin structure infections.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Micr | 2002 |
Cutaneous anthrax: a concise review.
Topics: Administration, Oral; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Doxycycl | 2002 |
Cutaneous anthrax: an overview.
Topics: Adult; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Chil | 2002 |
6 trials available for ciprofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bac | 2008 |
Naturally occurring cutaneous anthrax: antibiotic treatment and outcome.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Fe | 2012 |
Paederus dermatitis in Sierra Leone.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Bacterial Agents; Cetirizine; Ci | 2006 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug | 1995 |
A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Double-Blind Method; Female; Huma | 1998 |
Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Ag | 1999 |
59 other studies available for ciprofloxacin and Bacterial Skin Diseases
Article | Year |
---|---|
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug | 2018 |
Suspected cutaneous anthrax in rural areas.
Topics: Adolescent; Adult; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Female; Humans; Male; | 2019 |
[Increase in methicillin-resistant and ciprofloxacin-susceptible Staphylococcus aureus in osteoarticular, skin and soft tissue infections].
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Joint Diseases; Meth | 2020 |
Cutaneous mycobacteriosis in a captive Amazonian manatee Trichechus inunguis.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Male; Mycobacterium fortuitum; Mycoba | 2018 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus ant | 2013 |
Papulopustular eruption after holiday in a 44-year-old man. Whirlpool dermatitis (pseudomonas folliculitis).
Topics: Adrenal Cortex Hormones; Adult; Baths; Ciprofloxacin; Diagnosis, Differential; Folliculitis; Humans; | 2013 |
Field-based PCR for rapid diagnosis of cutaneous anthrax in the deployed setting using the joint biological agent identification and diagnostic system.
Topics: Adolescent; Afghan Campaign 2001-; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin | 2013 |
[Four cases of cutaneous anthrax in Diyarbakir, Turkey].
Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cattle; Ciprofloxacin; Diagnosis, Diffe | 2013 |
A 50-year-old man with blistering skin lesions on both feet.
Topics: Blister; Ciprofloxacin; Disease Progression; Follow-Up Studies; Hawaii; Humans; Male; Middle Aged; N | 2013 |
Charbon: a classical presentation.
Topics: Adult; Agriculture; Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Hand Dermatoses; Humans; Male; Oc | 2014 |
Unusual cause of fatal anthrax meningitis.
Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Female; Humans; Meningitis; Middle Age | 2015 |
Cutaneous anthrax in a school teacher.
Topics: Anthrax; Anti-Bacterial Agents; Ciprofloxacin; Faculty; Humans; Male; Middle Aged; Skin Diseases, Ba | 2014 |
Cutaneous anthrax: evaluation of 28 cases in the Eastern Anatolian region of Turkey.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis | 2016 |
A Child With Septic Shock and Purpura.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, Combination; Female; Hu | 2016 |
A Case of Recalcitrant Actinomycosis Unresponsive to Antibiotic Therapy.
Topics: Actinomycosis; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agen | 2016 |
[Cutaneous anthrax: seven cases].
Topics: Adolescent; Adult; Animals; Anthrax; Anti-Infective Agents; Ciprofloxacin; Female; Humans; Male; Mid | 2009 |
[Acute dermohypodermitis of the right leg (S. putrefaciens) after sea bathing].
Topics: Acute Disease; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Leg Ulcer; Male; Oceans and Seas; | 2009 |
Mesotherapy and cutaneous Mycobacterium fortuitum infection.
Topics: Adult; Aesculus; Anti-Infective Agents; Biopsy; Ciprofloxacin; Cosmetic Techniques; Female; Humans; | 2009 |
Characteristics of cutaneous anthrax in Turkey.
Topics: Anthrax; Anti-Infective Agents; Ciprofloxacin; Developing Countries; Drug Therapy, Combination; Fema | 2009 |
Cutaneous Mycobacterium haemophilum infection in a kidney transplant recipient after acupuncture treatment.
Topics: Acupuncture Therapy; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Humans; Immunocompromised | 2011 |
Primary cutaneous infection with Bacillus megaterium mimicking cutaneous anthrax.
Topics: Adult; Anthrax; Bacillus megaterium; Ciprofloxacin; Diagnosis, Differential; Female; Follow-Up Studi | 2011 |
Tattoo-associated Mycobacterium haemophilum skin infection in immunocompetent adult, 2009.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Contact Tracing; Drug Therapy, Combinat | 2011 |
Cavitary pneumonia and skin lesions.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Female; H | 2012 |
Recent outbreak of cutaneous anthrax in Bangladesh: clinico-demographic profile and treatment outcome of cases attended at Rajshahi Medical College Hospital.
Topics: Adolescent; Adult; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bangladesh; Cattle; | 2012 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacteri | 2013 |
Atypical mycobacterial infection following blepharoplasty and full-face skin resurfacing with CO2 laser.
Topics: Anti-Infective Agents; Blepharoplasty; Ciprofloxacin; Female; Humans; Laser Therapy; Middle Aged; My | 2002 |
Cutaneous infection caused by Salmonella typhi.
Topics: Adult; Bacteremia; Biopsy, Needle; Ciprofloxacin; Endemic Diseases; Female; Follow-Up Studies; Human | 2003 |
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Facial Dermatos | 2005 |
An unusually extensive case of cutaneous anthrax in a patient with type II diabetes mellitus.
Topics: Aged; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Diabetes Mellitus, Type 2; | 2005 |
Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey.
Topics: Adolescent; Adult; Agriculture; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Baci | 2006 |
Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; | 2007 |
Ano-genital granulomatosis treated with ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Anus Diseases; Ciprofloxacin; Female; Genital Diseases, Female; Granul | 2009 |
Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial I | 1994 |
Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
Topics: Aged; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity | 1994 |
[Mycobacterium kansasii cutaneous infection].
Topics: Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Middle Aged; Minocycline; Mycobacterium In | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; D | 1993 |
Cutaneous and pulmonary infections caused by Mycobacterium vaccae.
Topics: Aged; Animals; Anti-Bacterial Agents; Cattle; Ciprofloxacin; Humans; Male; Middle Aged; Minocycline; | 1996 |
[Ciprofloxacin in treatment of common bacterial skin infections. Results of an open study in general practice].
Topics: Administration, Oral; Anti-Infective Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Drug A | 1996 |
An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: successful combined therapy with maternal plasma and ciprofloxacin.
Topics: Adoptive Transfer; Agammaglobulinemia; Anti-Infective Agents; Campylobacter Infections; Campylobacte | 1996 |
[Painful nodular lesions].
Topics: Adult; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Humans; Lymph Nodes; Male; Mycobact | 1998 |
Pacemaker pocket infection.
Topics: Acinetobacter Infections; Aged; Anti-Infective Agents; Ciprofloxacin; Humans; Male; Pacemaker, Artif | 1999 |
Mycobacterium ulcerans infection (Buruli ulcer): first reported case in a traveler.
Topics: Adult; Africa; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxa | 1999 |
A rare infection caused by Chryseomonas luteola.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Diabetes C | 2000 |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Clarithromycin; DNA, Ribosomal; Drug Therapy, C | 2000 |
Anthrax. Deadly delivery.
Topics: Anthrax; Anti-Infective Agents; Bioterrorism; Ciprofloxacin; Humans; Respiratory Tract Infections; S | 2001 |
Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
Topics: Adult; Aged; Anthrax; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Female | 2001 |
Attempts to stem Anthrax fears stumble.
Topics: Adrenal Cortex Hormones; Anthrax; Bacillus anthracis; Bioterrorism; Centers for Disease Control and | 2001 |
Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
Topics: Adult; Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Chi | 2001 |
Cutaneous Bacillus anthracis infection.
Topics: Adult; Anthrax; Anti-Infective Agents; Arm; Bacillus anthracis; Ciprofloxacin; Humans; Male; New Yor | 2001 |
Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.
Topics: Adult; Amoxicillin; Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bioterrorism; Breast Fee | 2001 |
From the Centers for Disease Control and Prevention. Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001.
Topics: Adult; Aged; Anthrax; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Ciprofloxacin; Female | 2001 |
From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
Topics: Adult; Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Chi | 2001 |
From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
From the Centers for Disease Control and Prevention. Recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax.
Topics: Adult; Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bioterrorism; Breast Feeding; Child; | 2001 |
From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
[Skin nodules and ulcers of the limbs in a patient with rheumatoid arthritis].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Antitubercular Agents; Arthritis | 2002 |
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Topics: Aerobiosis; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Drug Resistance, Multiple, Bacterial | 2002 |